B-SOFT Co.,Ltd. operates in the medical and health informatization industry in China. The company provides smart hospital services, including outpatient registration and appointment center, medical technology appointment center, inpatient and outpatient services, and internet + hospital cloud platform. It also offers scientific research big data platform and specialized scientific research platform; clinical laboratory management platform, physical examination management information systems, image storage and communication systems, clinical anesthesia systems, and intensive care information systems; mobile doctor workstation and mobile nursing systems; multidisciplinary team consultation systems; clinical decision support systems; epidemic prevention and control solutions; and Hi-HIS multi-morphic intelligent connectivity management information systems. In addition, the company provides management decision support, smart integrated management, hospital medical insurance risk management, performance management, smart management applications, low-value consumables management systems, high-value consumables traceability management systems, consumables transaction supervision platform, and drug trade supervision platform; smart hospital infrastructure; a multidisciplinary telemedicine platform; and 5G pre-hospital emergency care. Further, it offers smart medical insurance solutions, including medical security information platform, DRG/DIP hospital applications, and single-disease quality management and control. Additionally, the company provides regional collaboration, regional management, primary healthcare, big data national health information platform, women and children’s cloud, and county-level medical consortium, as well as city-level health service platforms. B-SOFT Co.,Ltd. was founded in 1997 and is based in Hangzhou, China.
Metrics to compare | 300451 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship300451PeersSector | |
|---|---|---|---|---|
P/E Ratio | −24.8x | −9.1x | −0.5x | |
PEG Ratio | 0.00 | 0.51 | 0.00 | |
Price/Book | 2.0x | 2.9x | 2.6x | |
Price / LTM Sales | 7.7x | 7.7x | 3.3x | |
Upside (Analyst Target) | 6.4% | 20.3% | 45.0% | |
Fair Value Upside | Unlock | −4.2% | 5.1% | Unlock |